DYADIC INTERNATIONAL INC 8-K

What Happened

• Dyadic International, Inc. (DYAI) filed an 8-K reporting that on March 27, 2026 it received a deficiency notice from Nasdaq Listing Qualifications stating the company does not meet the technical minimum continued listing requirement under Nasdaq Rule 5550(b). The notice does not have an immediate effect on the listing of Dyadic’s common stock.

Key Details

• Nasdaq Rule 5550(b) requires at least one of: $2.5 million in stockholders’ equity; $35 million market value of listed securities; or $500,000 net income from continuing operations. Dyadic is currently noncompliant with that standard.
• The company has 45 calendar days from March 27, 2026 (until May 11, 2026) to submit a plan to regain compliance; if accepted, a cure period of up to 180 days (to September 23, 2026) may apply.
• Dyadic remains separately out of compliance with Nasdaq’s $1.00 minimum bid price rule (Rule 5550(a)(2)) and has until June 17, 2026 to regain compliance with the bid-price requirement.
• Dyadic said it intends to monitor compliance and evaluate options to resolve the deficiency, likely aiming to meet the $2.5 million stockholders’ equity standard. The company may appeal Nasdaq’s determination if needed.

Why It Matters

• A sustained failure to cure either the continued listing or minimum bid price deficiencies could lead to delisting from the Nasdaq Capital Market, which would reduce liquidity and could negatively affect the trading and valuation of Dyadic’s stock.
• There is no immediate change to the listing status, but investors should watch the May 11 and June 17 deadlines and any plan or disclosures the company files about how it will regain compliance. The 8-K also reiterates forward-looking risk factors (capital needs, regulatory acceptance, etc.) already disclosed in Dyadic’s SEC filings.